No Link Between Prenatal Tylenol Use and Autism, ADHD, Multiple Studies Confirm

Recent research has reinforced the safety of using Tylenol (acetaminophen) during pregnancy, dispelling previous concerns about a potential association with autism and attention deficit hyperactivity disorder (ADHD). A series of peer-reviewed studies published in 2026, including a significant 20-year study from Hong Kong, have shown no evidence linking the medication to an increased risk of these neurodevelopmental conditions.

The discussion around Tylenol began to intensify in September 2025 when the Trump administration raised alarms about possible links between the medication and autism. This prompted the Food and Drug Administration (FDA) to revise Tylenol’s labeling to include a warning about a possible connection to autism and ADHD. However, experts in the medical community quickly challenged this assertion, emphasizing that no causal relationship had been established.

The National Institute of Environmental Health Sciences has stated that the exact causes of autism remain unclear, making it crucial for discussions about medication use during pregnancy to be based on solid evidence. Steven J. Fleischman, MD, president of the American College of Obstetricians and Gynecologists (ACOG), has expressed concerns over the implications of these claims, suggesting that they could mislead pregnant women who may need to rely on Tylenol for pain relief or fever management.

A comprehensive systematic review and meta-analysis published in March 2026 further confirmed that there is no evidence to support the notion that acetaminophen increases risks for autism, ADHD, or intellectual disabilities. This review followed other large-scale studies, including one from Denmark that analyzed data from 1.5 million children and found no significant correlation between prenatal Tylenol exposure and autism.

The Hong Kong study, published in JAMA Internal Medicine, examined 708,020 mother-child pairs and utilized sibling-matched analysis to evaluate outcomes. Researchers found that prenatal exposure to acetaminophen did not correlate with an increased risk of autism or ADHD, regardless of dosage or timing of exposure.

In a similar vein, the Danish study reported that 3% of children not exposed to Tylenol were diagnosed with autism, compared to just 1.8% of those who had been exposed in utero. This finding remained consistent after adjusting for various risk factors, including the timing of exposure during pregnancy.

Experts like G. Thomas Ruiz, MD, an OB-GYN, have emphasized that acetaminophen is generally safe for pregnant women, particularly compared to other pain relievers like ibuprofen, which can cross the placenta and pose risks to the fetus. The potential health risks associated with untreated pain or fever during pregnancy can outweigh the unsupported claims about Tylenol.

Despite earlier studies suggesting a link between prenatal acetaminophen use and neurodevelopmental issues, medical professionals urge caution in interpreting these findings. Many emphasize that correlation does not imply causation and that the conditions are multifactorial, influenced by numerous factors beyond medication use.

In conclusion, the consensus among health experts is clear: Tylenol remains a generally safe option for managing pain and fever during pregnancy, and current research indicates no link to autism or ADHD. Pregnant individuals should continue to consult their healthcare providers regarding the use of medications to ensure both maternal and fetal health.